How has listing on the NYSE sped up Mindray’s overseas expansion?
Xu Hang: Listing overseas has been very helpful. In many countries, we used to “plead” with distributors to sell our products. Now the tables have turned; distributors actively approach us because they know us and know we are a good company. Many SME medical equipment manufacturers now approach us for cooperation or acquisition. After listing, we greatly influenced small and medium-sized companies in the U.S. and also shocked the international giants. During the first half-year, our overseas business increased 70 percent, while the domestic business increased 40 percent. The LINK: Mindray now sells products in more than 140 countries and territories. What differences do you find among these markets? Xu Hang: Our products are available in nine languages and are adapted to the operating norms of different markets – some countries apply European standards; others apply U.S. standards. Since the Chinese standards only apply to China, it is very likely that a product that Chinese doctors fi
